TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
FRA:NKB2 (USA)   Ordinary Shares
€ 42.8 +0.80 (+1.9%) Aug 19
18.86
P/B:
13.10
Market Cap:
€ 6.84B ($ 7.98B)
Enterprise V:
€ 7.01B ($ 8.11B)
Volume:
0
Avg Vol (2M):
192.00
Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (FRA:NKB2) Operating Data Charts